337 related articles for article (PubMed ID: 23721135)
21. Clinical value of whole-body magnetic resonance diffusion weighted imaging on detection of malignant metastases.
Li C; Liu ZS; Du XM; He L; Chen J; Wang W; Sun F; Du F; Luo ZG; Xue ZL; Zhao Y; Zhou CW
Chin Med Sci J; 2009 Jun; 24(2):112-6. PubMed ID: 19618609
[TBL] [Abstract][Full Text] [Related]
22. Assessment of the extent of metastases of gastrointestinal carcinoid tumors using whole-body PET, CT, MRI, PET/CT and PET/MRI.
Seemann MD; Meisetschlaeger G; Gaa J; Rummeny EJ
Eur J Med Res; 2006 Feb; 11(2):58-65. PubMed ID: 16504962
[TBL] [Abstract][Full Text] [Related]
23. Whole body magnetic resonance with diffusion weighted sequence with body signal suppression compared to (18)F-FDG PET/CT in newly diagnosed lymphoma.
Ferrari C; Minoia C; Asabella AN; Nicoletti A; Altini C; Antonica F; Ficco M; Guarini A; Maggialetti N; Rubini G
Hell J Nucl Med; 2014; 17 Suppl 1():40-9. PubMed ID: 24392468
[TBL] [Abstract][Full Text] [Related]
24. Respiratory-gated ¹⁸F-FDG PET/CT for the diagnosis of liver metastasis.
Suenaga Y; Kitajima K; Aoki H; Okunaga T; Kono A; Matsumoto I; Fukumoto T; Tanaka K; Sugimura K
Eur J Radiol; 2013 Oct; 82(10):1696-701. PubMed ID: 23768610
[TBL] [Abstract][Full Text] [Related]
25. Whole-body nonenhanced PET/MR versus PET/CT in the staging and restaging of cancers: preliminary observations.
Huellner MW; Appenzeller P; Kuhn FP; Husmann L; Pietsch CM; Burger IA; Porto M; Delso G; von Schulthess GK; Veit-Haibach P
Radiology; 2014 Dec; 273(3):859-69. PubMed ID: 25102372
[TBL] [Abstract][Full Text] [Related]
26. High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system.
Schmidt GP; Baur-Melnyk A; Herzog P; Schmid R; Tiling R; Schmidt M; Reiser MF; Schoenberg SO
Invest Radiol; 2005 Dec; 40(12):743-53. PubMed ID: 16304476
[TBL] [Abstract][Full Text] [Related]
27. Staging of colon cancer: whole-body MRI vs. whole-body PET-CT--initial clinical experience.
Squillaci E; Manenti G; Mancino S; Cicciò C; Calabria F; Danieli R; Schillaci O; Simonetti G
Abdom Imaging; 2008; 33(6):676-88. PubMed ID: 18373114
[TBL] [Abstract][Full Text] [Related]
28. Application of whole-body MRI to detect the recurrence of lung cancer.
Lee MH; Kim SR; Park SY; Park SJ; Lee EJ; Jin GY; Lee YC
Magn Reson Imaging; 2012 Dec; 30(10):1439-45. PubMed ID: 22817957
[TBL] [Abstract][Full Text] [Related]
29. Prospective observational study on diagnostic accuracy of whole-body MRI in solid small round cell tumours.
Kembhavi SA; Rangarajan V; Shah S; Qureshi S; Arora B; Juvekar S; Laskar S; Vora T; Chinnaswamy G; Ramadwar M; Kurkure P
Clin Radiol; 2014 Sep; 69(9):900-8. PubMed ID: 24863003
[TBL] [Abstract][Full Text] [Related]
30. Whole-body diffusion-weighted imaging: technical improvement and preliminary results.
Li S; Sun F; Jin ZY; Xue HD; Li ML
J Magn Reson Imaging; 2007 Oct; 26(4):1139-44. PubMed ID: 17896396
[TBL] [Abstract][Full Text] [Related]
31. Whole-body MR-DWIBS vs. [18F]-FDG-PET/CT in the study of malignant tumors: a retrospective study.
Cafagna D; Rubini G; Iuele F; Maggialetti N; Notaristefano A; Pinto D; Niccoli-Asabella A; Palmiotti G; Lasciarrea M; Maggialetti A
Radiol Med; 2012 Mar; 117(2):293-311. PubMed ID: 21744252
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT.
Schmidt GP; Baur-Melnyk A; Haug A; Heinemann V; Bauerfeind I; Reiser MF; Schoenberg SO
Eur J Radiol; 2008 Jan; 65(1):47-58. PubMed ID: 18082989
[TBL] [Abstract][Full Text] [Related]
33. Whole-body diffusion-weighted magnetic resonance imaging in the staging of oncological patients: comparison with positron emission tomography computed tomography (PET-CT) in a pilot study.
Stecco A; Romano G; Negru M; Volpe D; Saponaro A; Costantino S; Sacchetti G; Inglese E; Alabiso O; Carriero A
Radiol Med; 2009 Feb; 114(1):1-17. PubMed ID: 19082787
[TBL] [Abstract][Full Text] [Related]
34. [Whole-body staging of malignant melanoma: advantages, limitations and current importance of PET-CT, whole-body MRI and PET-MRI].
Pfannenberg C; Schwenzer N
Radiologe; 2015 Feb; 55(2):120-6. PubMed ID: 25589421
[TBL] [Abstract][Full Text] [Related]
35. Integrated whole-body PET/MR hybrid imaging: clinical experience.
Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
[TBL] [Abstract][Full Text] [Related]
36. Comparison between whole-body MRI with diffusion-weighted imaging and PET/CT in staging newly diagnosed FDG-avid lymphomas.
Albano D; Patti C; La Grutta L; Agnello F; Grassedonio E; Mulè A; Cannizzaro G; Ficola U; Lagalla R; Midiri M; Galia M
Eur J Radiol; 2016 Feb; 85(2):313-8. PubMed ID: 26781135
[TBL] [Abstract][Full Text] [Related]
37. Comparison of four MRI protocols for detection of extrahepatic colorectal cancer metastases.
Sivesgaard K; Jöhnk ML; Larsen LP; Sørensen M; Kramer S; Løgager VB; Hansen F; Pedersen EM
J Magn Reson Imaging; 2017 Dec; 46(6):1619-1630. PubMed ID: 28301099
[TBL] [Abstract][Full Text] [Related]
38. Accuracy of Whole-Body DWI for Metastases Screening in a Diverse Group of Malignancies: Comparison With Conventional Cross-Sectional Imaging and Nuclear Scintigraphy.
Paruthikunnan SM; Kadavigere R; Karegowda LH
AJR Am J Roentgenol; 2017 Sep; 209(3):477-490. PubMed ID: 28678578
[TBL] [Abstract][Full Text] [Related]
39. Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging.
Yi CA; Shin KM; Lee KS; Kim BT; Kim H; Kwon OJ; Choi JY; Chung MJ
Radiology; 2008 Aug; 248(2):632-42. PubMed ID: 18552311
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of dual-source parallel RF excitation for diffusion-weighted whole-body MR imaging with background body signal suppression at 3.0 T.
Mürtz P; Kaschner M; Träber F; Kukuk GM; Büdenbender SM; Skowasch D; Gieseke J; Schild HH; Willinek WA
Eur J Radiol; 2012 Nov; 81(11):3614-23. PubMed ID: 22178311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
